Placentrex-injectie

📦 Elke bestelling is gedekt door onze Reshipment Assurance Policy — als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.

Waarom bestellen bij MedsBase

Onze generieke medicijnen zijn afkomstig van WHO-GMP gecertificeerde fabrikanten en worden wereldwijd verzonden in discrete, eenvoudige verpakkingen — geen medicijnnaam op de buitenkant van het pakket. Betalingen met kaart worden verwerkt via een gereguleerde processor (betalingsoverzichten vermelden een gereguleerde kaartbetalingprocessor — nooit “MedsBase” of een medicijnnaam). Crypto en SEPA bankoverschrijvingen worden ook geaccepteerd. Elke bestelling wordt ondersteund door ons Reshipment Assurance Policy.

What Is Placentrex Injection?

Placentrex Injection is a biologic preparation containing a sterile aqueous extract of fresh, healthy human placenta. Each 2 ml ampoule delivers a concentrated blend of growth factors, cytokines, amino acids, nucleotides, enzymes and trace elements that collectively stimulate tissue repair. Manufactured by Albert David Ltd in India, Placentrex has been used in clinical dermatology, gynaecology and wound care for over six decades and is prescribed both in hospital settings and in specialist outpatient practice.

The injection is intended for intramuscular administration only and is not suitable for intravenous use. Each ampoule is supplied in a glass container with a colourless to pale yellow solution; a faint characteristic odour is normal. Placentrex is manufactured under GMP conditions with validated viral-inactivation processes so the finished product is safe for human therapeutic use.

Uses of Placentrex Injection

Placentrex Injection is clinically prescribed for a range of conditions where accelerated tissue healing or immunomodulation is required:

• Chronic non-healing wounds and ulcers — diabetic foot ulcers, venous leg ulcers, pressure sores and post-surgical wounds that are failing to heal through routine dressings alone.
• Pelvic inflammatory disease (PID) — as an adjunct to antibiotic therapy in chronic pelvic inflammation, helping reduce residual inflammation and adhesion formation.
• Pelvic tuberculosis — alongside standard anti-tubercular therapy to support recovery of inflamed pelvic tissue.
• Osteoarthritis pain — off-label use in the symptomatic management of joint inflammation and chronic arthritic pain.
• Dermatologic conditions — off-label in chronic eczema, radiation dermatitis, and post-inflammatory hyperpigmentation where tissue repair is the therapeutic goal.

How Placentrex Works

The therapeutic activity of Placentrex is attributed to a broad spectrum of bioactive peptides present in placental tissue. Key active components include epidermal growth factor (EGF), fibroblast growth factor (FGF), vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), interleukins, and placental lactogen. Together, these molecules stimulate fibroblast proliferation, collagen deposition, angiogenesis (new blood-vessel formation) and keratinocyte migration — the core cellular processes required for wound closure and tissue regeneration.

Placentrex also exerts a mild immunomodulatory effect, down-regulating excessive inflammatory signalling while supporting beneficial immune functions. This combination of pro-healing and anti-inflammatory activity explains its utility across wound care, pelvic inflammatory conditions and dermatology.

Dosering en toediening

Placentrex Injection is administered by a qualified healthcare professional. Self-injection is not recommended. The usual adult dosage depends on the indication:

The injection is given deep intramuscularly, typically into the gluteal or deltoid muscle. The physician may adjust frequency and course length based on clinical response.

How to Use Placentrex Injection

Placentrex is supplied as single-use glass ampoules. Before administration, the ampoule is inspected for clarity (a faint yellow tinge is normal), snapped at the scored neck, and the contents drawn into a sterile syringe. The injection should be given slowly into a clean, disinfected injection site. The patient should remain seated or supine for a few minutes after injection. The contents of a single ampoule must be used within minutes of opening; unused contents must be discarded.

Side Effects of Placentrex Injection

Placentrex is generally well tolerated. Most side effects are mild and localised to the injection site.

• Vaak voorkomend: mild injection-site pain, redness, warmth or transient swelling; low-grade fever in the first 24 hours.
• Minder vaak: itching at the injection site, mild rash, headache, nausea.
• Zeldzaam maar ernstig: allergic reaction (hives, difficulty breathing, swelling of face or throat) — seek emergency care. Sterile abscess at the injection site if administration technique is not aseptic.

Precautions and Warnings

Certain groups require extra caution or should avoid Placentrex entirely:

• Pregnancy and lactation: safety has not been established; use is generally avoided unless clearly needed.
• Known hypersensitivity to human proteins: contraindicated in patients with documented reactions to placental products.
• Autoimmune conditions: discuss with your physician — immunomodulatory activity may interact with disease flares or immunosuppressive therapy.
• Active infection at intended injection site: avoid local administration until resolved.
• Concurrent corticosteroid therapy: may reduce placental extract’s wound-healing benefit — clinical decision required.

Geneesmiddelinteracties

Formal drug-interaction studies with Placentrex are limited. Theoretical considerations include reduced efficacy when combined with systemic corticosteroids or cytotoxic chemotherapy (both of which impair wound healing), and additive immunomodulation when co-administered with biologic disease-modifying agents. Always inform the prescribing physician about all current medications, including over-the-counter supplements and herbal remedies.

Opslag

Store Placentrex Injection ampoules between 2 °C and 8 °C (standard refrigeration), protected from light and freezing. Do not use if the ampoule appears cloudy or contains visible particles. Keep out of reach of children. Discard any unused solution after opening.

Veelgestelde vragen

What is Placentrex Injection used for?

Placentrex is used primarily for chronic non-healing wounds, pelvic inflammatory disease and pelvic tuberculosis. It is also prescribed off-label for osteoarthritis pain, post-surgical tissue repair and selected dermatologic conditions where accelerated healing is the goal.

Is Placentrex Injection safe?

Placentrex has a long-established safety profile when administered by a qualified professional. The manufacturing process includes viral inactivation steps, and the injection has been used in Indian clinical practice for over 60 years. Side effects are generally mild and limited to the injection site.

How often is Placentrex Injection given?

Frequency depends on indication. For wound healing, a typical course is 2 ml given daily or on alternate days for 14–21 days. For pelvic inflammatory disease, 2 ml on alternate days for 10–15 injections is common. Your physician will tailor frequency to your clinical response.

Can Placentrex be used for skin rejuvenation?

Off-label use in aesthetic dermatology is practised in some settings for scar improvement, post-inflammatory hyperpigmentation and general skin rejuvenation. Results vary considerably; Placentrex is not approved specifically as a cosmetic treatment and evidence for purely aesthetic indications is limited.

What is Placentrex made from?

It is prepared from fresh, healthy human placenta collected under strict screening. The tissue is processed, sterilised and concentrated into a clear aqueous solution containing bioactive peptides. Manufacturing includes viral-inactivation steps to ensure patient safety.

Can I self-inject Placentrex at home?

No. Placentrex must be administered intramuscularly by a trained healthcare professional who can ensure correct technique, manage any immediate reaction and document the course. Self-injection is not recommended.

Are there vegetarian or plant-based alternatives?

Placentrex itself is derived from human placental tissue and has no direct vegetarian equivalent. Patients who prefer plant-based or synthetic alternatives may discuss recombinant growth factor preparations or advanced wound-care dressings with their physician.

Waarom bestellen bij MedsBase

Placentrex Injection is supplied through a WHO-GMP certified manufacturer with full COA documentation. We ship worldwide in plain, discreet packaging, and every order is covered by our Reshipment Assurance Policy. Uw betalingsbeschrijving bij betaling per kaart toont de gereguleerde betalingsverwerker (een gereguleerde kaartbetalingverwerker), nooit “MedsBase” of een medicijnnaam.

In procedures requiring enhanced drug dispersion through subcutaneous tissue — hypodermoclysis, regional anaesthesia augmentation, or spreading factor in cosmetic filler reversal — Hynidase Injection (hyaluronidase) is the adjuvant of choice and is available alongside Placentrex at MedsBase.

Other Anti-Inflammatory & Autoimmune Medications

If Placentrex Injection does not suit your situation, the following options are available in this category:

• Kenacort Injection (Triamcinolone acetonide 10/40 mg/mL) — IM/IA depot steroid
• Solu-Medrol (Methylprednisolone IV 40/125/500 mg) — IV pulse for severe inflammation
• Tess Oral Paste (Triamcinolone 0.1%) — topical mucosal anti-inflammatory
• Wysolone (Prednisolone 5/10/20 mg, Wyeth) — oral corticosteroid
• Conimune ME (Cyclosporine 25/50/100 mg) — calcineurin inhibitor

More options in Anti Inflammatory & Autoimmune Care

Gerangschikt op recente bestelvolumes van MedsBase — wat andere klanten in deze categorie kiezen.

Hisone

US$30.00 – US$235.00Preisspanne: US$30.00 bis US$235.00

Conimune ME

US$45.00 – US$220.00Preisspanne: US$45.00 bis US$220.00

Septilin

US$11.00 – US$41.00Preisspanne: US$11.00 bis US$41.00

Azoran

US$26.00 – US$116.00Preisspanne: US$26.00 bis US$116.00